Objectives: The interpretation of studies on quality of life (QoL) after lung surgery is often difficult owing to the use of multiple instruments with inconsistent scales and metrics. Although a more standardized approach would be desirable, the most appropriate instrument to be used in this setting is still largely undefined. The aim of the study was to assess the respective ability of two validated QoL instruments (European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30/L13 and Short Form (36) Health Survey (SF-36)) to detect perioperative changes in QoL of patients submitted to pulmonary resection for non-small-cell lung cancer (NSCLC). Methods: A prospective study on 33 consecutive patients (May 2009-December 2009) was submitted to pulmonary resection. All patients completed both EORTC QLQ-C30 with lung module 13 and SF-36 pre-and postoperatively (3 months). Preoperative changes of all SF-36 and EORTC scales were assessed by using the Cohen's effect-size method. External convergence between different instruments (SF-36 vs EORTC) was assessed by measuring the correlation of scales evaluating the same concepts (physical, psychosocial, and emotional). The correlation coefficients between standardized perioperative changes (effect sizes) of objective functional parameters (forced expiratory volume in 1 s (FEV1) and diffusion lung capacity for carbon monoxide (DLCO)) and SF-36 or EORTC scales were also investigated. Results: A poor correlation (r < 0.5) was detected between most of the scales of the two instruments measuring the same QoL concepts, indicating that they may be complementary in investigating different aspects of QoL. Only the SF-36 and EORTC social functioning scales and the SF-36 mental health and EORTC emotional functioning scales had a correlation coefficient >0.5. In general, EORTC was more sensitive in detecting physical or emotional declines but was more conservative in detecting improvements. Both SF-36 and EORTC showed poor correlations (r < 0.5) between perioperative changes in QoL and FEV1 or DLCO, confirming that objective parameters cannot be surrogates to the subjective perception of QoL. In particular, there was a poor correlation between perceived changes in dyspnea and objective changes in FEV1 or DLCO. Conclusions: EORTC behaved similarly to SF-36 in assessing perioperative changes in generic QoL scales, but, with the use of its lung module, provided a more detailed evaluation of specific symptoms. For this reason, EORTC should be regarded as the instrument of choice for measuring QoL in the thoracic surgery setting. #
Introduction
Quality of life has become a predominant issue when analyzing outcomes of surgical treatment for non-small-cell lung cancer (NSCLC). Recently, even the United States Food and Drug Administration (FDA) has given prominence to this field, considering the assessment of Quality of Life (QoL) as an important measure of treatment efficacy for every new drug therapy developed [1] .
Despite the fact that, in recent years, much progress has been made in conceptualizing health and formulating strategies for its measurement, no standardized metrics has been accepted as the gold standard in our specialty. Major outstanding issues include reliability and validity, sensitivity to changes among different stages of diseases, generic versus disease-specific survey, aggregation of items for scoring, and user's understanding and acceptance [2, 3] .
A search in PubMed revealed that, since 2000, 60% of articles focusing on perioperative changes of QoL after pulmonary resection with administration of both preoperative and postoperative questionnaires used SF-36 and 40% European Organization for Research and Treatment of Cancer (EORTC). The interpretation of the results reported in these studies and the comparison of their data to draw meaningful inferences appear scientifically unreliable if not based on a direct comparative analysis between the two most commonly used instruments. While SF-36 was developed for use in the generic population and across disease groups [4] , EORTC has been originally developed and validated for clinical cancer trials [5] . Accordingly, the use of EORTC in candidates to pulmonary resection can be criticized due to the lack of documented validity in this population. Although these two instruments have been previously compared in other non-surgical settings (showing satisfactory psychometric properties) [6] [7] [8] [9] , they have never been compared in thoracic surgery patients. This appears of importance as EORTC has been used extensively in thoracic surgical patients (with or without induction or adjuvant treatment), particularly in the most recent period, and this use has never been challenged against a more generic questionnaire such as SF-36, already largely used in our and other specialties. Moreover, the EORTC QoL group and European Society of Thoracic Surgeons (ESTS) have recently agreed to organize a collaborative project aimed to develop a specific survey for surgical patients. The present study may constitute a useful resource information to elaborate further on the subject.
The objective of this study was to analyze the respective ability of these two validated QoL instruments (EORTC Quality of Life-30 (EORTC QL-30) together with its specific Lung module L13 vs SF-36) to detect perioperative changes in QoL and symptoms in patients submitted to pulmonary resection for NSCLC.
Patients and methods
This is a prospective longitudinal study on 33 consecutive patients submitted to pulmonary resection (25 lobectomies, six wedge/segmentectomies and two pneumonectomies) from May 2009 to December 2009 for NSCLC at a single center. In all patients, QoL was assessed before and after (3 months) the operation by the administration of both the EORTC QLQ-C30 together with lung module 13 and the Short Form 36v2 (SF-36v2) surveys. The study was approved by the local Institutional Review Board of the hospital, and all patients gave their informed consent to participate in the study. All patients were available for postoperative follow-up.
Two patients received induction and three received adjuvant chemotherapy. Operability exclusion criteria included a ppoFEV1 and ppoDLCO below 30%, in addition to a maximal O 2 uptake (VO 2 ) peak lower than 10 ml kg À1 min
À1
. As a rule, all operations were performed through a lateral muscle-sparing, nerve-sparing [10] thoracotomy by boardcertified thoracic surgeons.
All patients were extubated in the operating room and transferred to a dedicated thoracic ward. Postoperative management focused on early mobilization, anti-thrombotic and antibiotic prophylaxis, and physical and respiratory rehabilitation. Thoracotomy chest pain was assessed at least twice daily and controlled through a systemic continuous infusion of non-opioid drugs. Therapy was titrated to achieve a visual analog score below than 5 (in a scale ranging from 0 to 10) during the first 48-72 h. This regimen was usually switched to an oral therapy after the removal of chest tubes. No formal preadmission or post-discharge physiotherapy or psychological supportive programs were administered.
Neurological or psychotropic personal medications, if present, were generally resumed the day following surgery.
The SF-36v2 questionnaire [4, 11] is a generic instrument assessing eight health physical and mental concepts (PF: physical functioning, RP: role limitation caused by physical problems, BP: bodily pain, GH: general health perception, VT: vitality, SF: social functioning, RE: role limitation caused by emotional problems, and MH: mental health). Scores standardized to norms and weighted averages are used to create summary physical component summary (PCS) and mental component summary (MCS) scores on a standard scale. In the SF-36v2, all health dimension scores are standardized to norms by employing a linear transformation of data originally scored on a 0-100 scale. Norm-based scores have a mean of 50 and a standard deviation of 10. As a consequence, for all health dimensions and component scales, any score <50 falls below the general population mean and each point represents 1/10th of a standard deviation. This allows for a direct comparison of measures among different populations and scales.
The EORTC QoL Core Questionnaire (EORTC QLQ-C30) [5] is a cancer-specific 30-item questionnaire for assessing the health-related QoL. Twenty-four questions form nine multiitem scales presenting various aspects of QoL, whereas the remaining six are single-item scales describing different cancer-relevant symptoms. It assesses five functional scales (physical functioning: PF; role functioning: RF; emotional functioning: EF; cognitive functioning: CF; and social functioning: SF), nine symptoms scales (fatigue; nausea and vomiting; pain; dyspnea; insomnia; appetite loss; constipation; diarrhea; and financial difficulties) and a global health status scale. In addition, EORTC features a specific lung cancer module (LC13) including 10 symptoms scales (dyspnea, coughing, hemoptysis, sore mouth, dysphagia, peripheral neuropathy, alopecia, pain in chest, pain in arm or shoulder, and pain in other parts).
A linear transformation is used to standardize the raw score of all scales and single-item measures, so that scores range from 0 to 100; a higher score represents a higher ('better') level of functioning, or a higher ('worse') level of symptoms [12] .
Statistical analysis
The relevance of the perioperative changes in all SF-36 or EORTC scales were measured by the Cohen's effect size method (mean change of the variable divided by its baseline standard deviation) [13] . An effect size >0.8 (or <À0.8) is regarded as large and clinically relevant, whereas effect sizes between 0.3 and 0.8 or lower than 0.3 are regarded as medium or small, respectively [14] .
The external convergence between SF-36 and EORTC was assessed by testing the degree of correlation between the same concept scales of the two instruments. Correlation coefficients between effect sizes of objective parameters (forced expiratory volume in 1 s (FEV1) and diffusion lung capacity for carbon monoxide and (DLCO)) and SF-36 or EORTC scales were also assessed.
Statistical analysis was performed on the Stata 9.0 statistical software.
Results
The characteristics of the 33 patients included in the analysis are shown in Table 1 .
The average preoperative SF-36-PCS and MCS were 51.6 and 42.6, respectively. The average preoperative EORTC QLQ-C30 global health scale (GHS) was 70.5.
The average postoperative SF-36-PCS and MCS were 47.4 and 42.7, respectively. The average postoperative EORTC QLQ-C30 GHS was 64. 9 . Tables 2 and 3 show the mean preoperative and postoperative values of all SF-36, EORTC QLQ-30, and EORTC LC13 scales, with their respective effect sizes.
The analysis of the standardized mean differences between preoperative and postoperative values of SF-36 showed that the average effect sizes were never above 0.8 or below À0.8 for any of the domains. An average medium (effect size 0.3-0.8) decline was observed in PCS, PF, RP, and BP. A small average decline was observed in the RE domain (effect size 0.25) ( Table 2 and Fig. 1) .
However, three patients (9%) had a large improvement and 14 (42%) a large decline in PCS. Six patients (18%) had a large improvement, whereas seven (21%) had a large decline in MCS.
Standardized changes in EORTC QLQ-C30 and L13 domains between preoperative and postoperative periods were assessed using the same methodology.
EORTC QLQ-C30 survey was able to detect average large changes (effect size greater than 0.8 or lower than À0.8) in some functional or symptom scales. An average large decline in RF, and a large increase in pain, dyspnea, and appetite loss was reported. Moreover, medium declines (effect size 0.3-0.8) in PF, and an increased fatigue, constipation, and diarrhea were also found (Table 3 and Fig. 2 ).
In addition, the EORTC QLQ-L13 module was able to detect a large perceived increase in alopecia, and a medium postoperative worsening in dyspnea, coughing, chest pain, sore mouth, and pain in arm or shoulder (Table 3 and Fig. 3 ).
Two patients (6%) showed a large improvement and seven (21%) a large decline in their Global Health Scale (GHS). Two (6%) had a large improvement and 11 (33%) a large decline in their physical functioning. Five patients (15%) had a large improvement and eight (24%) in their emotional functioning. Three patients (9%) reported to large relief and 15 (45%) a large worsening of their dyspnea.
We were not able to find relevant correlations between subscales assessing the similar underlying QoL. In fact, there was a poor (r < 0.4) correlation between either SF-36 PCS or MCS and EORTC GHS scales. The SF-36 PCS was poorly correlated with its EORTC counterpart. SF-36 RP or RE scales were poorly correlated with EORTC RF scale. SF-36 RE was poorly correlated with EORTC EF scale. SF-36 mental health scale was poorly correlated with both EORTC CF and SF scales. The only domains we were able to find correlated (r > 0.5) were SF-36 SF and its EORTC counterpart (r = 0.55) and SF-36 mental health scale with EORTC EF (r = 0.57) ( Tables 4 and 5 ).
The average perioperative reduction of FEV1 and DLCO was 13% and 4%, respectively. The standardized perioperative average changes of FEV1 and DLCO are À0.53 and À0.25, respectively. Only one patient had a large improvement in FEV1, whereas four had a large improvement in DLCO. On the other hand, 11 patients (33%) had a large decline in FEV1 and six (18%) in DLCO.
The correlation coefficients between standardized perioperative changes of FEV1 and DLCO and the standardized changes of all SF-36 and EORTC domains were all lower than 0.4, indicating poor correlation between objective and subjective perioperative measures. In particular, there was poor correlation between perceived changes in dyspnea and objective changes of FEV1 and DLCO.
Discussion
The evaluation of QoL has become the focus of an increasing number of investigations, emphasizing the importance of patients' concerns and expectations about surgery.
QoL can be assessed with generic instruments (i.e., applicable in a broad range of conditions allowing for comparisons between diseases), or disease-specific ones (i.e., their use is restricted to a specific disease and only comparisons between patient groups with the same condition are possible). Disease-specific tools are clinically sensitive, often have a good conceptual validity, and may be more responsive than generic instruments [15] .
In cancer patients, many instruments have been used to assess their QoL, ranging from generic ones, such as the SF-36 Health Survey [11, 14, 16, 17] , to specific measures such as Functional Living Index -Cancer (FLIC) [18] , CARES [19] , and Functional Assessment of Cancer Therapy (FACT) [20] . However, of the few self-completed disease-specific questionnaires that can be considered valid, reliable, and sufficiently brief to be of practical use in the clinical research setting, the EORTC QLQ-C30 [4] has been the most widely used in Europe.
SF-36 and EORTC are the two most commonly used QoL surveys in our specialty. Their choice is often not explained and is based on personal preferences rather than on [ ( ) T D $ F I G ] Fig. 3 . Line chart displaying the standardized perioperative mean differences (effect sizes) of the scales of LC-13 module. documented validity studies in this population. Indeed, EORTC was originally developed and validated for clinical cancer trials [5] , and its use in candidates to pulmonary resection has never been challenged against a more generic tool such as the SF-36. Although these two instruments have been previously compared in other non-surgical settings (showing satisfactory psychometric properties) [6] [7] [8] [9] , they have never been compared in thoracic surgery patients. This information has important clinical and scientific implications in our setting, as it may help to interpret the results of longitudinal studies using multiple generic or disease-specific instruments.
The increased importance of QoL in our clinical practice and patients' management warrants to identify a more uniform approach by the identification of a reliable and reproducible instrument, which could be used consistently in future investigations.
Therefore, the objective of our study was to compare the respective performance of the two most commonly used QoL instruments in our setting (SF-36 and EORTC C30).
By using a standardized mean method to account for differences in metrics, we found that, with the exception of SF-36 SF and its EORTC counterpart and SF-36 mental health scale with EORTC EF, the scales of the two instruments measuring similar concepts are poorly correlated between each other. This may indicate that they may be complementary and possibly detect different aspects of QoL. This finding may also be explained by a different construct of the items used to score the domain.
Although the proportion of patients reporting perioperative large changes in their physical and emotional domains was found to be similar by using the two instruments, EORTC C-30 and, particularly, its Lung module (L13) certainly provided a more extensive and complete assessment of symptoms. Using this instrument, we were able to detect large and clinically meaningful perioperative changes (effect size greater of 0.8 or lower than À0.8) in RF, pain, dyspnea, appetite loss, and alopecia.
Moreover, EORTC has been designed to capture physical and emotional perceptions during the last week and in this differs from SF-36, of which questions relate to the last 4 weeks. In this regard, EORTC may be more accurate particularly when one wants to explore changes in QoL during a short follow-up period (such as the one selected for this study). This temporal difference (favoring EORTC) may explain some of the discrepancies found in the comparison between the two instruments.
Perioperative changes in physical and emotional scales, as assessed by both instruments, were not correlated with perioperative changes in physiologic parameters such as FEV1 or DLCO, confirming that perceived subjective QoL needs specific instruments to be evaluated and cannot be inferred by physiologic measurable surrogates [21] .
To our knowledge, this is the first comparison between two QoL instruments in a surgical cohort of lung cancer patients.
Other authors have previously tried to compare different QoL tools in non-surgical oncologic settings.
Kuenstner and colleagues, investigating convergent validity of EORTC QLQ-C30, SF-36, and FLIC questionnaires, concluded that, despite their general characters, overall health subscales cannot be equated, while most specific subscales provide valid results [6] .
In a study using a large cohort of Italian breast and colon cancer survivors, Apolone and colleagues [7] comparing EORTC QLQ-C30 and SF-36 found a high correlation between scales assessing similar concepts (physical, psychological, or general health). However, in that article, only a postinterventional setup was made without investigating on the ability of instruments to detect changes in different types of cancer or treatment-free survivors.
In a study of 134 oncologic patients, Porzsolt and colleagues [8] found that EORTC QLQ-30 and SF-36 provided comparable information, particularly for the physical functioning scale and symptom scales of pain and fatigue. However, they also emphasized important differences between the two instruments. In fact, only the EORTC includes a scale measuring the 'overall quality of life' and the RF scales of the two instruments were not comparable for their different questions' construct.
Fredheim and colleagues [9] assessed the correlation between EORTC QLQ-C30 and SF-36 among patients with chronic non-malignant pain. They found that EORTC QLQ-C30 scales have unsatisfactory internal consistency but, similar to SF-36, had overall acceptable psychometric properties. Therefore, they discovered correlations between EORTC QLQ-C30 and SF-36 measures of the same concept.
Our study may have potential limitations:
the small sample size precluded more in-depth analyses regarding sensitivity, discrimination, internal consistency, and construct validity of the two QoL instruments; all operations were included from wedge to pneumonectomy; although the purpose of this investigation was not to assess perioperative changes in QoL relative to operation, but rather to verify the convergence of the two instruments in assessing these changes, we cannot completely rule out the possibility that the two surveys behave differently in different surgical populations; further investigations with larger sample sizes are needed to address this specific issue; the two questionnaires were administered at the same time and the patient chose which to complete first; many questions in the two surveys are similar; a recall bias cannot be completely ruled out and appears inherent to this type of study; the completion of the two questionnaires by the patients was cumbersome for some of them, taking up to 1 h for some patients to go through all items and respond to all questions; this may have detracted from the accuracy of the second survey; however, as the order of completion of questionnaires was left to the random choice of the patient, this factor may have influenced equally the accuracy of the two instruments; only two instruments were analyzed, and the results should not be generalized beyond the instruments used in this study; and QoL has been shown to continue to improve up to 6-12 months; theoretically, responses of the two QoL instruments could be affected by the period of evaluation; thus, the generalization of our findings for a longer follow-up time needs to be confirmed [22, 23] .
In conclusion, we were able to demonstrate in a small cohort of lung cancer surgical patients that, although the scales of SF-36 and EORTC are poorly correlated, the two instruments are able to detect a similar proportion of patients showing clinically relevant changes in their physical and emotional scales. However, EORTC was more accurate in detecting symptom changes. Although our results need to be independently confirmed by other studies with larger sample sizes, they seem to warrant the use of a disease-specific instrument such as EORTC to assess QoL in lung resection patients.
way around, or was it random? I raise this because at the end of 200 questions you may be tired.
Dr Pompili: No. We decided to give them at random and altogether. The patients decided the order of completion. Many of them chose the SF-36 first because it is shorter. Dr Internullo: So there is a bias towards the SF-36? Dr Pompili: This is possible because the second time you answer almost the same questions, and in that case you may be inclined to give similar answers by a recall bias.
